Order number: M3139.0050Shipping: shipped on wet ice, store at -20°C
Free of shipping costs!
Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.
PHOENIXDX® 2019-NCOV is a real-time RT-PCR-based detection system for the 2019 Wuhan coronavirus (2019-nCoV). The kit comes as 20-time RT-PCR master mix.
PHOENIXDX® 2019-NCOV is a real-time RT-PCR-based detection system for the 2019 Wuhan coronavirus (2019-nCoV). 2019-nCoV is considered a novel human coronavirus that is genetically distinct from the common human coronaviruses (229E, NL63, OC43, HKU1), which cause seasonal acute respiratory illness. It is also genetically distinct from the two newer human coronaviruses, MERS-CoV and SARS-CoV.
PHOENIXDX® 2019-NCOV detects the presence of two different and highly specific gene sequences of 2019-nCoV: E gene and RdRP gene.
Additionally, a non-infectious positive control is included. The positive control is used to confirm functionality of the assays and overall PCR performance, the negative human extraction control assay is included to evaluate the quality of the RNA isolation independently from the 2019-nCoV assays.
All primers and probes are tested to be not contaminated with template RNA or DNA (positive control RNA).
20-time RT-qPCR master mix with
1 x 150µL PhoenixDx® Enzyme Mix
1 x 750µL PhoenixDx® E gene Mix
1 x 750µL PhoenixDx® RdRP Mix
1 x 750µL PhoenixDx® HEC Mix
1 x 200µL 2019-nCoV Target Positive Control (TPC)
Enzyme mix for 50 x 20µL qPCR reactions
application:SARS-CoV-2 RT-qPCR realtime PCR
Sicherheits Hinweise / Safety
Klassifizierungen / Classificationeclass-Nr: 34-16-04-90
Dokumente - Protokolle - Downloads
Here you will find information and further literature on PHOENIXDX® 2019-NCOV. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: email@example.com or phone: +49 731 3608 123.